How to buy BioMarin Pharmaceutical shares

Learn how to easily invest in BioMarin Pharmaceutical shares.

Promoted
Freetrade logo
Get a free £10-£100 stock
Fund your new account with at least £50
Free share typically revealed within 7-10 days
Go to site
Capital at risk. T&C's apply.

Biomarin Pharmaceutical Inc (BMRN) is a publicly traded biotechnology business based in the US which employs around 3,400 staff. BioMarin Pharmaceutical is listed on the NASDAQ and traded in US dollars. Its current price of $70.35 is 16.6% down on its price a month ago ($84.38).

How to buy shares in BioMarin Pharmaceutical

  1. Open a brokerage account. Choose from our top broker picks or compare brokers in depth. Then, complete an application.
  2. Fund your account. Add money to your account via bank transfer, debit card or credit card.
  3. Search the platform by ticker symbol. BMRN in this case.
  4. Choose an order type. Place a market order or limit order with your preferred number of shares or dollar amount.
  5. Submit the order. It's that simple.
The whole process can take as little as 15 minutes. You'll need a smartphone or computer, an internet connection, your passport or driving licence and a means of payment.

Our top picks for where to buy BioMarin Pharmaceutical shares

Best for 0% commission stocks
eToro Free Stocks logo
Finder Award
Go to site
Capital at risk. Fees apply.
Copy picks from top traders
4.3 ★★★★★
Commission-free trades
Fractional shares
Get dividend payments
Best for uninvested cash
XTB logo
Go to site
Capital at risk. T&Cs apply.
Earn 5% on uninvested funds
4.4 ★★★★★
Commission-free trades
Fractional shares
5,400+ stocks/ETFs
Best for customer satisfaction
Hargreaves Lansdown Fund and Share Account logo
Finder Award
Go to site
Capital at risk. T&Cs apply.
97% would recommend
4.2 ★★★★★
Free fund trading
Expert insights
Wide range of accounts

Fees calculator for buying BioMarin Pharmaceutical shares with popular apps

Both exchange rates and share prices fluctuate in real time, so the costs estimated here should be considered as a guide only. They don't factor in spreads, which can be hard to pin down. Always refer to the platform itself for availability and pricing.

Quantity of shares

12
Platform Finder Score Account fee Min. initial deposit Trade cost Link
eToro Free Stocks logo
4.3 ★★★★★
£0 $100 £650.83
Go to siteCapital at risk
Freetrade logo
4.4 ★★★★★
£0 £1 £652.38
Go to siteCapital at risk
XTB logo
4.4 ★★★★★
£0 £0 £649.21
Go to siteCapital at risk
Hargreaves Lansdown Fund and Share Account logo
4.2 ★★★★★
£0 £1 £664.39
Go to siteCapital at risk

Full comparison of share dealing platforms

These providers cover a wide range of stocks, but we can't guarantee they'll all offer this stock.

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.


Alternative ways to invest in BioMarin Pharmaceutical

Buying shares in just one company is generally considered a riskier bet than investing in a range of investments - AKA a "diversified portfolio". Experts generally recommend holding a mix of investments in specific assets and funds. Funds are ready-made portfolios of multiple companies' shares (potentially including BioMarin Pharmaceutical), and the idea is that drops in the value of one constituent company's share price might be offset by rises in others.

BioMarin Pharmaceutical is a major part of the NASDAQ, so it's included in many global funds and investment trusts, as well as tracker-style exchange traded funds (ETFs).

Is it a good time to buy BioMarin Pharmaceutical stock?

Review technicals and fundamentals to help you determine if now's a good time for you to invest.

Technical analysis

View BioMarin Pharmaceutical's price performance, share price volatility, historical data and technicals.

Use our graph to track the performance of BMRN stock over time.

Historical closes compared with the last close of $70.35

1 week (2024-10-03)-96.43%
1 month (2024-09-11)-16.63%
3 months (2024-07-11)-17.25%
6 months (2024-04-11)-23.72%
1 year (2023-10-11)-18.71%
2 years (2022-10-10)-96.52%
3 years (2021-10-11)-10.53%
5 years (2019-10-10)-96.43%

The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.

Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.

Promoted
eToro Free Stocks
Invest in BioMarin Pharmaceutical shares
Finder Award
  • Start investing from $50
  • Pay no stamp duty on UK shares
  • Commission-free trading. Other fees may apply.

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.


Is BioMarin Pharmaceutical under- or over-valued?

Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the BioMarin Pharmaceutical P/E ratio, PEG ratio and EBITDA.

BioMarin Pharmaceutical's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 52x. In other words, BioMarin Pharmaceutical's shares trade at around 52x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the United States stock markets on average as of November 09, 2023 (20.44). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

BioMarin Pharmaceutical's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.4155. A PEG ratio below 1 can be interpreted as meaning the shares are not overvalued given the current rate of growth.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into BioMarin Pharmaceutical's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

BioMarin Pharmaceutical's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $349.4 million (£0.0 million).

The EBITDA is a measure of BioMarin Pharmaceutical's overall financial performance and is widely used to measure a its profitability.

Frequently asked questions

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.


More guides on Finder

  • How to buy Flutter Entertainment shares

    Thinking about buying shares in Flutter Entertainment? We explain how to do it and compare a range of providers who will give you access to global markets.

  • How to buy Dettol shares | 4626p

    Sales of Reckitt Bencksier products like Dettol have risen due to coronavirus. Here’s how you can invest in Dettol, by buying Reckitt Benckiser shares.

  • How to buy AT&T shares

    Ever wondered how to buy shares in AT&T? We explain how and compare a range of providers that can give you access to many brands, including AT&T.

  • How to buy Wincanton shares

    Ever wondered how to buy shares in Wincanton? We explain how and compare a range of providers that can give you access to many brands, including Wincanton.

  • How to buy United Utilities Group shares

    Ever wondered how to buy shares in United Utilities? We explain how and compare a range of providers that can give you access to many brands, including United Utilities.

  • How to buy Relx shares

    Find out how to buy shares in RELX, see its share prices over the last three months and check out our must-do checklist if you’re looking to invest.

  • How to buy Reach shares

    Ever wondered how to buy shares in Reach? We explain how and compare a range of providers that can give you access to many brands, including Reach.

  • How to buy WPP shares

    Ever wondered how to buy shares in WPP Group? We explain how and compare a range of providers that can give you access to many brands, including WPP Group.

  • How to buy Merlin Entertainments shares

    Find out how to buy shares in Merlin Entertainments, see Merlin Entertainments’ share prices over the last three months and check out our must-do checklist if you’re looking to invest.

  • How to buy Howden Joinery Group shares

    We explain how to buy shares in Howden Joinery, explaining the costs and fees you could come up against. We also have a checklist for anyone looking to invest in a company.

Go to site